Lyndi Hirsch Has Spent 25 Years Making Complex Choices Easier

Long before the waiting-room screen became a media channel, Lyndi Hirsch was learning what happens when a new idea meets an old anxiety: somebody has to explain it. In 1996, early in a career that would span biotechnology, digital publishing and consumer technology, she worked on the launch of a self-injectable treatment. The internet was a destination, not an atmosphere. People did not walk into appointments with search results in their pockets. Information moved more slowly, and the marketer's job carried a peculiar burden. Clarity was not decoration. It was part of how a person found enough confidence to act.

Thirty years later, Hirsch is still working on that handoff between information and decision. The scenery has changed repeatedly. She has held roles at Biogen, Serono, Genentech, Human Genome Sciences and MAP Pharmaceuticals; moved into the digital world at MedPage Today and Everyday Health; helped build consumer campaigns at Dermira; and taken senior posts at AdhereTech, Medisafe and GoodRx. In January 2026 she became chief marketing officer of CheckedUp, a New York company whose digital network lives precisely where questions become consequential: waiting rooms and exam rooms.

A résumé with that many logos can look like a collection. Hirsch's reads more like a relay. Each job passes the same baton to a new medium. The product launch gives way to the health publisher, the publisher to the connected device, the device to the medication-access platform, and the platform to point-of-care media. The enduring subject is not a channel. It is the person on the receiving end.

A career built at the translation desk

Hirsch studied human communications and public relations at the University of Northern Colorado from 1986 to 1991. It is difficult to imagine a more literal preface to what followed. Her early roles put her in the machinery of specialty-product marketing, including marketing communications at Biogen, product management at Serono, patient and nurse promotion at Genentech, consumer marketing at Human Genome Sciences and online and consumer marketing at MAP Pharmaceuticals.

Those titles matter less than the accumulating skill beneath them. Specialty launches require a marketer to work between several languages at once: scientific evidence, regulatory boundaries, commercial goals, professional practice and ordinary human concern. There is no room for the airy promise that might survive in a sneaker campaign. The audience needs to know what something is, why it matters and what to do next. The order is unforgiving.

Hirsch eventually saw that the distribution of those answers was changing. From 2013 to 2017, she served in senior marketing strategy at MedPage Today and Everyday Health. Her later biography described the move as a response to the healthcare industry's eventual reliance on digital and virtual communications. The phrasing is almost quaint now. Digital won so thoroughly that it disappeared into daily life. At the time, crossing from drug commercialization into health media was a deliberate wager on where attention was going.

The point is not merely to reach people

At Dermira, where she led consumer marketing, Hirsch helped launch the Check Your Sweat and QBREXZA campaigns. Industry judges noticed. DTC Perspectives named her among its Top 25 DTC Marketers of 2020. The recognition arrived at the edge of another turn: in April of that year, she joined AdhereTech as chief marketing officer.

AdhereTech offered a neat expression of the career theme. Its technology connected a physical product with reminders, communication and live support. Marketing was no longer confined to getting somebody interested. It could participate in what happened after the decision, when motivation became routine and routine was tested by real life. On a 2021 podcast, Hirsch was introduced as a science communicator who kept patients at the front of the work. In 2022, she chaired a health-monitoring showcase at the Precision Medicine World Conference and spoke about engagement through real-time connection.

Next came Medisafe, where she joined as senior vice president of strategic marketing, and then GoodRx, where she became vice president of marketing for Manufacturer Solutions. The progression moved her closer to a stubborn fact: awareness means little if a person cannot get from a prescription to the product. At a 2025 direct-to-patient discussion, she contrasted the empowered modern consumer with the frictions that still interrupt access. The person now had more information and agency than in 1996, but also more tabs open, more choices and more chances to stop.

“The only thing better than helping one patient is scaling that to help dozens, hundreds, or thousands of patients.”Lyndi Hirsch

That sentence explains both the attraction and the trap of marketing at scale. A dashboard can show millions of impressions while concealing whether a single message was useful. Hirsch's public record keeps returning to the counterweight: data should sharpen empathy, not replace it. When PM360 named her an ELITE 100 Patient Advocate in 2024, it highlighted her interest in predictive technology alongside her record of building communities and support programs. The machine could help identify what people might need next. The human still had to decide whether the intervention deserved their attention.

The work outside the job description

Hirsch's nonprofit work predates several of the companies on her résumé. She has been involved with Race to Erase MS since 1997, serving over time as a patron chair and business advisor. She joined the National Association for Continence board in 2020 and now serves as vice chair. Her volunteer list also includes Habitat for Humanity, Second Harvest Food Banks, the Wounded Warrior Project, and the Lupus and Arthritis Foundations.

This is not an ornamental paragraph at the bottom of a corporate biography. Board work asks for a different kind of attention. Constituents are not market segments. Many are navigating systems without the benefit of expertise, time or influence. Hirsch once described contributing “time, treasure, and talents,” an old philanthropic phrase that becomes more interesting when the talent in question is translation. Knowing how to organize information, earn notice and build a durable community has value well beyond a product launch.

Colleagues describe the manner behind the method. One wrote that Hirsch could “see around corners,” ask the right questions and build bridges across teams, while bringing generosity and humor to the room. Recommendations are naturally affectionate documents, but the details fit the career: curiosity, collaboration and an ability to connect creative work to a commercial outcome. The best operators are translators inside the building, too.

There is a more domestic footnote in her board biography. Hirsch is a native New Yorker who lives on Long Island, close to family, with a black Labrador named Tessa. Corporate profiles seldom improve with a dog, yet this one does. A career devoted to understanding behavior ought to include at least one companion unimpressed by the quarterly plan.

Now the message meets the room

CheckedUp hired Hirsch to lead marketing strategy, brand positioning and patient engagement. The company delivers educational and brand content through waiting-room televisions and interactive exam-room wallboards across specialty practices. At the time of her appointment, CheckedUp said it had recorded 40 percent year-over-year growth. By August, when Providence Equity Partners announced an agreement to acquire a majority stake, the network had reached more than 17,000 specialty providers and 15 million patients.

Those figures create the scale Hirsch has spent years approaching from different directions. They also create a demanding assignment. CheckedUp's new investment is intended to expand its provider network and therapeutic reach, build products and technology, and advance data and analytics. Earlier in the summer, the company received Media Rating Council accreditation for reporting on advertising delivered through its waiting-room network. Growth and measurement, in other words, have become immediate facts of the job.

Yet the point-of-care setting resists the usual swagger of media. Nobody enters an exam room because they are bored and looking for content. Attention there is contextual, finite and earned. A message must respect the conversation already in progress. This makes CheckedUp a logical destination for a marketer who has spent years considering the gap between reach and usefulness.

“By delivering meaningful, data-driven engagement at the point of care, we have a real opportunity to help patients make more informed decisions and improve the care experience.”Lyndi Hirsch, on joining CheckedUp

Hirsch arrives with awards from PM360, DTC Perspectives and PharmaVoice, plus the authority conferred by multiple first-in-class launches. But the sharper credential may be the variety of places from which she has watched a decision form. She has seen the message at launch, on a publisher's page, inside a connected product, alongside a price search and now on a screen in the room where a question can be asked aloud.

The career contains ambition, though not the sort that needs fireworks. It is the ambition to make communication useful at greater scale without sanding away the individual. The tools will keep changing. Artificial intelligence, predictive models and new measurement systems will promise more precision. Hirsch has already made clear that she thinks those tools belong on a marketer's radar. Her longer record supplies the necessary condition: technology matters when it improves the experience of the person rather than merely improving the report about them.

That is the durable idea hidden inside the busy résumé. The work is not to simplify a person until they fit the message. It is to make a complex message worthy of the person.